Skip to main content
ROSSARI BIOTECH LIMITED logo

ROSSARI BIOTECH LIMITED — Investor Relations & Filings

Ticker · ROSSARI ISIN · INE02A801020 LEI · 335800R7XFRR8ZTHBQ25 BSE.NS Manufacturing
Filings indexed 526 across all filing types
Latest filing 2025-04-25 Regulatory Filings
Country IN India
Listing BSE.NS ROSSARI

About ROSSARI BIOTECH LIMITED

https://www.rossari.com/

Rossari Biotech Limited is a specialty chemicals manufacturer focused on providing sustainable and innovative solutions across diverse sectors. The company operates through three primary business segments: Home, Personal Care and Performance Chemicals (HPPC), Textile Specialty Chemicals, and Animal Health and Nutrition. In the HPPC segment, it supplies essential ingredients for detergents, soaps, paints, and water treatment applications. Its textile division offers a comprehensive range of chemicals for the entire textile value chain, including pre-treatment, dyeing, and finishing processes. Additionally, the company provides high-quality feed additives and supplements for the poultry and livestock industries. Driven by robust research and development capabilities, Rossari Biotech emphasizes eco-friendly chemistry and customized formulations to meet specific client requirements. With advanced manufacturing facilities, the company serves a global clientele, maintaining a strong focus on operational excellence.

Recent filings

Filing Released Lang Actions
ESOP/ESOS/ESPS
Regulatory Filings
2025-04-25 English
ESOP/ESOS/ESPS
Regulatory Filings
2025-04-25 English
Dividend
Regulatory Filings
2025-04-25 English
Outcome of Board Meeting
Regulatory Filings
2025-04-25 English
Capacity addition
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, providing an update on capacity addition at the company's subsidiaries. It includes details about board approvals for capacity expansion, investment amounts, financing modes, and rationale for the projects. The document is an announcement of operational updates related to capacity expansion, not a financial report, earnings release, or management discussion. It is a regulatory announcement informing the stock exchanges and investors about material developments. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2025-04-24 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 95% confidence The document is an intimation letter about an upcoming earnings conference call for Q4 FY25, scheduled for April 28, 2025. It references Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements, indicating it is a regulatory announcement. The content includes details about the call timing, dial-in information, and a brief description of the company, but does not contain any actual financial results or substantive financial data. The document is relatively short (4696 characters) and serves to notify investors and analysts about the event rather than presenting the earnings report itself. Therefore, it is classified as a Call Transcript (CT) type document, specifically an announcement of an earnings conference call, which fits the Call Transcript category as it relates to the full text transcript or announcement of such calls.
2025-04-22 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.